Cytomedix, Inc. Receives Favorable Patent Ruling In U.S. District Court
LITTLE ROCK, Ark., March 26, 2004 (PRIMEZONE) — Cytomedix, Inc. (CYME:OTC.OB) today announced it has received a favorable ruling from United States […]
World's Largest Resource for Cardiovascular Perfusion
LITTLE ROCK, Ark., March 26, 2004 (PRIMEZONE) — Cytomedix, Inc. (CYME:OTC.OB) today announced it has received a favorable ruling from United States […]
The aim of our study was to investigate alterations in expression of adhesion molecules and L-selectin on neutrophils, and soluble adhesion molecules levels in CCHD children.
The number of heart transplants is decreasing due to organ shortage, yet the donor pool could be enlarged by improving graft preservation. Hypothermic machine perfusion (MP) has been shown to improve kidney, liver, or lung graft preservation.